![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
Objective To investigate the relationship between Tiam1 and lymphangiogenesis in human
colorectal carcinoma (CRC) tissues, as well as the expression of VEGF-C in a CRC cell line
(HCT116) after knockdown of the Tiam1 gene with RNA interference (RNAi). Methods The
expressions of Tiam1, Rac1, VEGF-C and Podoplanin in 50 samples of CRC were detected by
immunohistochemical analysis. The lymph microvessel density (LMVD) in Podoplanin positive
specimens was evaluated. The results were analyzed statistically to investigate the correlation of
Tiam1, VEGF-C, lymph node metastasis and other clinicopathological parameters. An shRNA
eukaryotic expression vector against Tiam1 gene was constructed and transfected into HCT116 cells.
The expression of Tiam1 gene was assessed by RT-PCR and western blot analysis. Results In the
specimens of CRC tissue, the positivity rate of Tiam1 and VEGF-C was 84% and 58%, respectively.
The positivity rate of VEGF-C in the Tiam1 positive group (64.3%) was significantly higher than
that in the Tiam1 negative group（25.0%）. The LMVD in the Tiam1 positive group（11.35±3.34）
was significantly higher than that in the Tiam1 negative group（7.38±2.27）.In addition, the
expression of the Tiam1 gene was efficiently blocked by RNAi. Down-regulation of Tiam1 gene
expression significantly suppressed HCT116 cell growth in vitro. Compared with untransfected
HCT116 cells, HCT116 cells transfected with pGenesil-1-Tiam1 plasmids showed a significant
decrease in the expression of VEGF-C. Conclusions We suggest that the Tiam1 gene may act as a
crucial therapeutic target for Lymphangiogenesis in CRC.